Evaluating the effect of Berberry root (Berberis vulgaris) as Adjuvant Treatment on the prevention of atypical Antipsychotic-Induced metabolic syndrome in Patients With Schizophrenia: A triple-blind, Randomized, Placebo-controlled Trial

Ahvaz University of Medical Sciences0 个研究点目标入组 106 人开始时间: 待定最近更新: 2021年6月21日

适应症

试验速览

暂无简介。

•Early diagnosis of schizophrenia
•They must have recently sought treatment or not received any medication in the past three months
•Study subjects should be screened for metabolic syndrome. In fact, all patients should be screened for glucose levels, blood lipids, blood pressure, and waist circumference, and ultimately only those with no or at most two of these symptoms should be included in the study
•The patient is able to take medicine
•Receive written consent from the patient or parents to enter the study

•Pregnant and lactating women
•Incidence of any side effects of the drug) stomach pain, diarrhea, constipation, bloating, headache, skin complications
•Existence of any severe and chronic physical diseases (brain, cardiovascular, neurological and seizure diseases, liver, diabetes, hypertension, hyperlipidemia, joints or history of substance use)
•Mental retardation
•People treated with antihypertensives, antihypertensives, anticoagulants, sedatives, and drugs that are metabolized by the liver.

发起方